BioNote Inc (377740)

Currency in KRW
5,190.00
-10.00(-0.19%)
Closed·
377740 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5,150.005,230.00
52 wk Range
4,150.006,320.00
Key Statistics
Bid/Ask
5,180.00 / 5,190.00
Prev. Close
5,200
Open
5,200
Day's Range
5,150-5,230
52 wk Range
4,150-6,320
Volume
48.77K
Average Volume (3m)
62.98K
1-Year Change
6.9001%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
377740 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

BioNote Inc Company Profile

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.

Employees
298

Compare 377740 to Peers and Sector

Metrics to compare
377740
Peers
Sector
Relationship
P/E Ratio
4.5x11.6x−0.6x
PEG Ratio
0.020.070.00
Price/Book
0.3x1.6x2.6x
Price / LTM Sales
4.6x2.7x3.4x
Upside (Analyst Target)
-24.6%41.1%
Fair Value Upside
Unlock23.8%5.3%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1,160.97%
Dividend Yield
3.85%
Industry Median 0.84%
Annualized payout
200.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 14, 2025
EPS / Forecast
177.00 / 48.40
Revenue / Forecast
29.50B / --
EPS Revisions
Last 90 days

377740 Income Statement

People Also Watch

906,000
267260
+1.57%
476,500
307950
-3.15%
8,620
005440
+1.77%
74,800
025540
+0.54%
50,000
005850
+6.04%

FAQ

What Is the BioNote (377740) Stock Price Today?

The BioNote stock price today is 5,190.00

What Stock Exchange Does BioNote Trade On?

BioNote is listed and trades on the Seoul Stock Exchange stock exchange.

What Is the Stock Symbol for BioNote?

The stock symbol for BioNote is "377740."

Does BioNote Pay Dividends? What’s The Current Dividend Yield?

The BioNote dividend yield is 3.85%.

What Is the BioNote Market Cap?

As of today, BioNote market cap is 526.06B.

What Is BioNote's Earnings Per Share (TTM)?

The BioNote EPS (TTM) is 1,160.97.

When Is the Next BioNote Earnings Date?

BioNote will release its next earnings report on Mar 03, 2026.

From a Technical Analysis Perspective, Is 377740 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BioNote Stock Split?

BioNote has split 0 times.

How Many Employees Does BioNote Have?

BioNote has 298 employees.

What is the current trading status of BioNote (377740)?

As of Jan 18, 2026, BioNote (377740) is trading at a price of 5,190.00, with a previous close of 5,200.00. The stock has fluctuated within a day range of 5,150.00 to 5,230.00, while its 52-week range spans from 4,150.00 to 6,320.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.